André Mira

  • Neuroregeneration
  • Neuroimmunology
  • Spinal Cord Injury
  • Pharmacological Therapy

André Vidinha-Mira joined the ReNeu team in ICVS (Life and Health Sciences Research Institute)/3B’s Associate Laboratory as a Research Fellow in 2022, supervised by Doctor Nídia de Sousa. His graduation in Human Biology was completed in 2016 at the School of Science and Technology, University of Évora. During his graduation, he performed an internship about Optogenetics in a Drosophila melanogaster model at CEDOC (Chronic Diseases Research Centre), Lisbon, under the supervision of Doctor César Mendes. He completed his Master’s Course in Neurobiology at School of Medicine, University of Porto, in 2019. His master thesis was supervised by Doctor Andreia Teixeira-Castro at ICVS, the subject being the Impact of Serotonergic Signalling in Neurodegeneration, in which he worked with mice models for Tauopathies and Parkison’s Disease, trying to unravel the benefits of serotonergic treatment in theses diseases. During this time, he developed a deep know-how of behavioural tests, and molecular and histological tissue analysis, which he has deepened throughout his current work. During his time at ICVS, he followed his main research interests, namely seeking possible treatments or therapies for diseases related to the nervous system.

André Mira

  • Neuroregeneration
  • Neuroimmunology
  • Spinal Cord Injury
  • Pharmacological Therapy

André Vidinha-Mira joined the ReNeu team in ICVS (Life and Health Sciences Research Institute)/3B’s Associate Laboratory as a Research Fellow in 2022, supervised by Doctor Nídia de Sousa. His graduation in Human Biology was completed in 2016 at the School of Science and Technology, University of Évora. During his graduation, he performed an internship about Optogenetics in a Drosophila melanogaster model at CEDOC (Chronic Diseases Research Centre), Lisbon, under the supervision of Doctor César Mendes. He completed his Master’s Course in Neurobiology at School of Medicine, University of Porto, in 2019. His master thesis was supervised by Doctor Andreia Teixeira-Castro at ICVS, the subject being the Impact of Serotonergic Signalling in Neurodegeneration, in which he worked with mice models for Tauopathies and Parkison’s Disease, trying to unravel the benefits of serotonergic treatment in theses diseases. During this time, he developed a deep know-how of behavioural tests, and molecular and histological tissue analysis, which he has deepened throughout his current work. During his time at ICVS, he followed his main research interests, namely seeking possible treatments or therapies for diseases related to the nervous system.

Scientific Highlights

Best Poster Presentation Award – YES Meeting 2021

Ferreira-Lomba, S. Guerreiro, D. Cunha-Garcia, J. Pereira-Sousa, S. Duarte-Silva, A. Teixeira-Castro, M.S. Kleven, D. Vilasboas-Campos, A. Vidinha-Mira, A. Newman-Tancredi, P. Maciel. Befiradol treatment ameliorated the motor dysfunction of Spinocerebellar Ataxia Type 3 mouse model. Neuroscience Applied, Volume 1, Supplement 2, 2022, http://dx.doi.org/10.1016/j.nsa.2022.100835

de Sousa, Nídia; Correia-Silva, Ariana; Pinho, Andreia; Vidinha-Mira, André ; Cainé, Laura; Lima, Marta; Santos, Diogo; Cibrão, Jorge ; Campos, Jonas ; Cavaleiro, Helena; Pinho, Tiffany; Afonso, João; Sampaio-Marques, Belém; Monteiro, Susana ; Silva, Nuno; Barreiro-Iglesias, Antón; Salgado, António. Baclofen modulates the immune response after spinal cord injury with locomotor benefits. (submitted)

Add Your Heading Text Here

Projects

As Leader

Projects

As Member

Basic mechanisms of degeneration/regeneration

This project dedicates to fundamental research to understand the molecular mechanisms underlying Parkinson’s Disease (PD) and Spinal Cord Injury (SCI) pathophysiology.

In the context of PD, we focus on addressing how…

Read More

Molecular Therapies

The remarkable advances in molecular biology in the past decades have led to a better understanding of the mechanisms implicated in the pathophysiology of many CNS disorders as well as mechanisms that control axonal regeneration…

Read More